{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:33:16Z","timestamp":1782862396548,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaut.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T18:25:32Z","timestamp":1530987932000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report"],"prefix":"10.1016","volume":"93","author":[{"given":"Amelia","family":"Ruffatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustina","family":"De Silvestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Calligaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Favaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Del Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mattia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-6071","authenticated-orcid":false,"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.07.001_bib1","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.001_bib2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.001_bib3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Euro-Phospholipid Project Group, Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.001_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.07.001_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS) Registry project group (European forum on antiphospholipid antibodies), catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry\u201d","volume":"32","author":"Cervera","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.001_bib6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"CAPS Registry project group (European forum on antiphospholipid antibodies), catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the international CAPS Registry","volume":"15","author":"Rodr\u00edguez-Pint\u00f3","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.001_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.berh.2016.07.004","article-title":"Catastrophic antiphospholipid syndrome: the current management approach","volume":"30","author":"Rodriguez-Pint\u00f3","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.001_bib8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0961203309106833","article-title":"The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome","volume":"18","author":"Bucciarelli","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2018.07.001_bib9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.autrev.2011.04.031","article-title":"Management of refractory cases of catastrophic antiphospholipid syndrome","volume":"10","author":"Espinosa","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.001_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.autrev.2015.11.009","article-title":"Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature","volume":"15","author":"Tenti","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.001_bib11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1538-7836.2008.03121.x","article-title":"Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification","volume":"6","author":"Ruffatti","year":"2008","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2018.07.001_bib12","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant\/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2018.07.001_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.49.3.184","article-title":"Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome","volume":"49","author":"Ostuni","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.001_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2796.1994.tb01036.x","article-title":"A catastrophic antiphospholipid syndrome: the importance of high levels of warfarin anticoagulation","volume":"235","author":"Ruffatti","year":"1994","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2018.07.001_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.autrev.2008.09.002","article-title":"Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature","volume":"8","author":"Bortolati","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.001_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2018.07.001_bib17","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.07.001_bib18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1160\/TH12-03-0212","article-title":"Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome","volume":"109","author":"Bontadi","year":"2013","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2018.07.001_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood-2014-06-576983","article-title":"Platelets as pivot in the antiphospholipid syndrome","volume":"124","author":"de Groot","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.07.001_bib20","first-page":"1","article-title":"The role of platelets in antiphospholipid syndrome","volume":"7","author":"Baroni","year":"2017","journal-title":"Platelets"},{"key":"10.1016\/j.jaut.2018.07.001_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jth.13947","article-title":"Thrombocytopenia in high-risk patients with antiphospholipid syndrome","volume":"16","author":"Pontara","year":"2018","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2018.07.001_bib22","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/art.22018","article-title":"Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients","volume":"54","author":"Bucciarelli","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.001_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.001_bib24","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jaut.2018.07.001_bib25","first-page":"30042","article-title":"Therapeutic apheresis in the treatment of catastrophic antiphospholipid syndrome","volume":"18","author":"\u00d6zg\u00fcr","year":"2018","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jaut.2018.07.001_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2796.2008.01942.x","article-title":"Plasma exchange for the management of the catastrophic antiphospholipid syndrome: importance of the type of fluid replacement","volume":"264","author":"Marson","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2018.07.001_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/BOR.0000000000000269","article-title":"Treatment of catastrophic antiphospholipid syndrome","volume":"28","author":"Kazzaz","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.001_bib28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.62.6.530","article-title":"Long term outcome of catastrophic antiphospholipid syndrome survivors","volume":"62","author":"Erkan","year":"2003","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118302786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118302786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:19:38Z","timestamp":1760257178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118302786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"alternative-id":["S0896841118302786"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.07.001","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}